Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kwon ED"" wg kryterium: Autor


Tytuł:
Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma.
Autorzy:
Parker AS
Leibovich BC
Lohse CM
Sheinin Y
Kuntz SM
Eckel-Passow JE
Blute ML
Kwon ED
Parker, Alexander S
Leibovich, Bradley C
Lohse, Christine M
Sheinin, Yuri
Kuntz, Susan M
Eckel-Passow, Jeanette E
Blute, Michael L
Kwon, Eugene D
Pokaż więcej
Źródło:
Cancer (0008543X); 5/15/2009, Vol. 115 Issue 10, p2092-2103, 12p
Czasopismo naukowe
Tytuł:
C-choline positron emission tomography/computed tomography for detection of disease relapse in patients with history of biochemically recurrent prostate cancer and prostate-specific antigen ≤0.1 ng/ml.
Autorzy:
Garg I; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Nathan MA; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Packard AT; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Kwon ED; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Larson NB; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Lowe V; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Davis BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Haloi R; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Mahon ML; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Goenka AH; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2021 Apr-Jun; Vol. 17 (2), pp. 358-365.
Typ publikacji:
Journal Article
MeSH Terms:
Kallikreins/*blood
Neoplasm Recurrence, Local/*diagnosis
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*diagnosis
Radiopharmaceuticals/*administration & dosage
Aged ; Carbon Radioisotopes/administration & dosage ; Carbon Radioisotopes/chemistry ; Choline/administration & dosage ; Choline/chemistry ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Positron Emission Tomography Computed Tomography ; Prostate/diagnostic imaging ; Prostate/pathology ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/therapy ; Radiopharmaceuticals/chemistry ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma.
Autorzy:
Eckel-Passow JE; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Ho TH; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.
Serie DJ; Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
Cheville JC; Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Houston Thompson R; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Costello BA; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Dong H; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Kwon ED; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Leibovich BC; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Parker AS; Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2020 Feb; Vol. 9 (3), pp. 1152-1160. Date of Electronic Publication: 2019 Dec 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
B7-H1 Antigen/*genetics
Biomarkers, Tumor/*genetics
Carcinoma, Renal Cell/*genetics
Kidney Neoplasms/*genetics
Programmed Cell Death 1 Receptor/*genetics
Adult ; Aged ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/secondary ; Carcinoma, Renal Cell/surgery ; Female ; Gene Expression Regulation, Neoplastic ; Genetic Heterogeneity ; Humans ; Kaplan-Meier Estimate ; Kidney/pathology ; Kidney/surgery ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Kidney Neoplasms/surgery ; Male ; Metastasectomy ; Middle Aged ; Nephrectomy ; Survival Analysis
SCR Disease Name:
Clear-cell metastatic renal cell carcinoma
Czasopismo naukowe
Tytuł:
Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.
Autorzy:
Zhang BY; Department of Internal Medicine, Mayo Clinic and Mayo Medical School, 200 First Street SW, Rochester, MN 55905, USA.
Thompson RH
Lohse CM
Dronca RS
Cheville JC
Kwon ED
Leibovich BC
Pokaż więcej
Źródło:
BJU international [BJU Int] 2013 Jun; Vol. 111 (7), pp. 1046-53. Date of Electronic Publication: 2013 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Antigens, Neoplasm/*metabolism
Biomarkers, Tumor/*metabolism
Carbonic Anhydrases/*metabolism
Carcinoma, Renal Cell/*metabolism
Kidney Neoplasms/*metabolism
Aged ; Carbonic Anhydrase IX ; Carcinoma, Renal Cell/mortality ; Cohort Studies ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Immunohistochemistry ; Kidney Neoplasms/mortality ; Male ; Middle Aged ; Necrosis/metabolism ; Nephrectomy ; Predictive Value of Tests ; Prognosis ; Surveys and Questionnaires ; Survival Analysis ; Time Factors
Czasopismo naukowe
Tytuł:
Endogenous tumor-reactive CD8 T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth.
Autorzy:
Liu X; Department of Urology; College of Medicine; Mayo Clinic; Rochester, MN USA.
Gibbons RM
Harrington SM
Krco CJ
Markovic SN
Kwon ED
Dong H
Pokaż więcej
Źródło:
Oncoimmunology [Oncoimmunology] 2013 Jun 01; Vol. 2 (6), pp. e23972. Date of Electronic Publication: 2013 Jun 06.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies